[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-334675-105":59,"doc-detail-334675-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","knowledge-mapping-of-immunotherapy-for-breast-cancer-a-bibliometric-analysis-from-2013-to-2022","Knowledge mapping of immunotherapy for breast cancer - A bibliometric analysis from 2013 to 2022","","Breast cancer remains the leading cause of cancer-related death among women worldwide, and immunotherapy has become a major milestone in modern oncology. This study performs a bibliometric analysis of immunotherapy research for breast cancer covering 2013–2022 using Web of Science Core Collection data. Co-occurrence of keywords (VOSviewer), co-citation and knowledge-base bursts (CiteSpace), and thematic evolution via bibliometrix identify hotspots. A total of 7,975 publications are analyzed, revealing six keyword clusters and rapid global growth.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/knowledge-mapping-of-immunotherapy-for-breast-cancer-a-bibliometric-analysis-from-2013-to-2022/334675/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/knowledge-mapping-of-immunotherapy-for-breast-cancer-a-bibliometric-analysis-from-2013-to-2022/334675.png","ImageObject",300,407,{"name":92,"@type":93},"Olivia Brown","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",12,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What is the purpose of this bibliometric analysis?","Question",{"text":113,"@type":114},"To provide a comprehensive overview of the research status on immunotherapy for breast cancer from 2013 to 2022, and to identify trends and hotspots.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"Which databases and tools are used for the analysis?",{"text":118,"@type":114},"The study uses publication data from the Web of Science Core Collection, with VOSviewer for keyword co-occurrence, CiteSpace for co-citation and knowledge-base bursts, and bibliometrix for thematic evolution.",{"name":120,"@type":111,"acceptedAnswer":121},"What topics emerged as the main research hotspots?",{"text":122,"@type":114},"Keyword co-occurrence reveals six major clusters, including tumor microenvironment, prognosis biomarker, immune checkpoints, novel drug delivery methods, immune cells, and therapeutic approaches.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},334675,1790119781,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":105,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":41,"preview_page_count":4},16904993612988,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","RESEARCH ARTICLE     \nKnowledge mapping of immunotherapy for breast cancer: A bibliometric analysis from 2013 to 2022  \nFanli Qua,b, Guanwen Wanga,b, Ping Wenc, Xiaoyu Liua,b, and Xiaohua Zenga,b  \naDepartment of Breast Cancer Center, Chongqing University Cancer Hospital, Chongqing, China; bChongqing Key Laboratory for Intelligent Oncology in Breast Cancer (iCQBC), Chongqing University Cancer Hospital, Chongqing, China; cSchool of Medicine, Chongqing University, Chongqing, China  \nABSTRACT  \nBreast cancer is the leading cause of cancer-related death among women globally. Immunotherapy has emerged as a major milestone in contemporary oncology. This study aims to conduct a bibliometric analysis in the field of immunotherapy for breast cancer, providing a comprehensive overview of the current research status, identifying trends and hotspots in research topics. We searched and retrieved data from the Web of Science Core Collection, and performed a bibliometric analysis of publications on immunotherapy for breast cancer from 2013 to 2022. Current status and hotspots were evaluated by cooccurrence analysis using VOSviewer. Evolution and bursts of knowledge base were assessed by cocitation analysis using CiteSpace. Thematic evolution by bibliometrix package was used to discover keywords trends. The attribution and collaboration of countries/regions, institutions and authors were also explored. A total of 7,975 publications were included. In co-occurrence analysis of keywords, 6 major clusters were revealed: tumor microenvironment, prognosis biomarker, immune checkpoints, novel drug delivery methods, immune cells and therapeutic approaches. The top three most frequently mentioned keywords were tumor microenvironment, triple-negative breast cancer, and programmed cell death ligand 1. The most productive country, institution and author were the USA (2926 publications), the University of Texas MD Anderson Cancer Center (219 publications), and Sherene Loi (28 publications), respectively. There has been a rapid growth in studies on immunotherapy for breast cancer worldwide. This research area has gained increasing attention from different countries and institutions. With the rising incidence of breast cancer, immunotherapy represents a research field of significant clinical value and potential.  \nARTICLE HISTORY  \nReceived 17 January 2024 Revised 11 March 2024 Accepted 24 March 2024  \nKEYWORDS  \nBreast cancer;  \nimmunotherapy; bibliometric; immune checkpoint; tumor microenvironment  \nIntroduction  \nBreast cancer is the most common malignant tumor in women. According to statistics from the World Health Organization, there were approximately 2.3 million new cases of breast cancer in 2020, accounting for 11.7% of all cancer cases.1 It is the leading cause of cancer-related death among women globally, imposing a significant burden on both health and economies. Breast cancer is a heterogeneous disease, with different molecular subtypes exhibiting distinct biological and clinical characteristics. Over the past three decades, significant advancements in targeted and adjuvant therapies have greatly improved the prognosis of early-stage disease. However, treatment options for advanced metastatic disease remain limited, with a median overall survival of 4–5 years for luminal subtype and 1 year for triplenegative subtype.2 Therefore, there is an urgent need to improve treatment modalities. Immunotherapy has emerged as a major milestone in contemporary oncology, revolutionizing the management of various solid tumors. This includes immune checkpoint inhibitors, cancer vaccines, antibody-drug conjugates (ADCs), oncolytic viruses, and adoptive cell therapy. The most extensively studied immunotherapeutic agents for breast cancer are immune checkpoint inhibitors.3 In normal circumstances,  \nthe immune system employs inhibitory checkpoint pathways to regulate immune responses against pathogens, preventing excessive responses and limiting tissue damage and a","cbCainzFXYBSOITo","https://ap.wps.com/l/cbCainzFXYBSOITo","pdf",8416585,"English","# Abstract\n# Introduction\n# Methods and Bibliometric Approach\n## Data source and time span\n## Keyword, co-citation, and thematic analyses\n# Results\n## Keyword clusters and hotspots\n## Country, institution, and author outputs\n# Article history and bibliographic information\n# Keywords and supplementary information","[{\"question\":\"What is the purpose of this bibliometric analysis?\",\"answer\":\"To provide a comprehensive overview of the research status on immunotherapy for breast cancer from 2013 to 2022, and to identify trends and hotspots.\"},{\"question\":\"Which databases and tools are used for the analysis?\",\"answer\":\"The study uses publication data from the Web of Science Core Collection, with VOSviewer for keyword co-occurrence, CiteSpace for co-citation and knowledge-base bursts, and bibliometrix for thematic evolution.\"},{\"question\":\"What topics emerged as the main research hotspots?\",\"answer\":\"Keyword co-occurrence reveals six major clusters, including tumor microenvironment, prognosis biomarker, immune checkpoints, novel drug delivery methods, immune cells, and therapeutic approaches.\"}]","Knowledge mapping of immunotherapy for breast cancer - A bibliometric analysis from 2013 to 2022 | PDF",1790007792]